MedTrace Logo

Crystalloids for AKI in Shock Patients

NCT03188614 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2017-06-15

No results posted yet for this study

Summary

Fluid resuscitation is important in shock therapy, but the choice of fluids, especially the choice of crystalloid is under debate. It is said that normal saline is related to hyperchloremia， which might lead to acute kidney injury. Thus the hypothesis of the study is to explicit whether balanced salt solution could reduce the incidence of acute kidney injury when compared with normal saline.

Conditions

  • Shock

Interventions

DRUG

Fluid resuscitation

The placebo group is resuscitated with normal saline, the experimental group is resuscitated with balanced fluid.

Sponsors & Collaborators

  • Southeast University, China

    lead OTHER

Principal Investigators

  • Haibo Qiu, Doctor · Southeast University

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-08-01
Primary Completion
2018-09-01
Completion
2018-10-01

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03188614 on ClinicalTrials.gov